These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

687 related articles for article (PubMed ID: 31686399)

  • 1. The Therapeutic Potential of Nanobodies.
    Jovčevska I; Muyldermans S
    BioDrugs; 2020 Feb; 34(1):11-26. PubMed ID: 31686399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NANOBODIES®: A Review of Diagnostic and Therapeutic Applications.
    Jin BK; Odongo S; Radwanska M; Magez S
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanobody: A Small Antibody with Big Implications for Tumor Therapeutic Strategy.
    Sun S; Ding Z; Yang X; Zhao X; Zhao M; Gao L; Chen Q; Xie S; Liu A; Yin S; Xu Z; Lu X
    Int J Nanomedicine; 2021; 16():2337-2356. PubMed ID: 33790553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanobodies in Human Infections: Prevention, Detection, and Treatment.
    Sanaei M; Setayesh N; Sepehrizadeh Z; Mahdavi M; Yazdi MH
    Immunol Invest; 2020 Nov; 49(8):875-896. PubMed ID: 31856615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of nanobodies in brain diseases.
    Zheng F; Pang Y; Li L; Pang Y; Zhang J; Wang X; Raes G
    Front Immunol; 2022; 13():978513. PubMed ID: 36426363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanobodies as Versatile Tools to Understand, Diagnose, Visualize and Treat Cancer.
    Van Audenhove I; Gettemans J
    EBioMedicine; 2016 Jun; 8():40-48. PubMed ID: 27428417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanobodies and their potential applications.
    Hassanzadeh-Ghassabeh G; Devoogdt N; De Pauw P; Vincke C; Muyldermans S
    Nanomedicine (Lond); 2013 Jun; 8(6):1013-26. PubMed ID: 23730699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanobodies: The Future of Antibody-Based Immune Therapeutics.
    Bathula NV; Bommadevara H; Hayes JM
    Cancer Biother Radiopharm; 2021 Mar; 36(2):109-122. PubMed ID: 32936001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanobodies Enhancing Cancer Visualization, Diagnosis and Therapeutics.
    Naidoo DB; Chuturgoon AA
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-Domain Antibodies or Nanobodies: A Class of Next-Generation Antibodies.
    Khodabakhsh F; Behdani M; Rami A; Kazemi-Lomedasht F
    Int Rev Immunol; 2018; 37(6):316-322. PubMed ID: 30741045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanobody-A versatile tool for cancer diagnosis and therapeutics.
    Liu M; Li L; Jin D; Liu Y
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jul; 13(4):e1697. PubMed ID: 33470555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenic biomolecules specific nanobodies application in cancer imaging and therapy; review and updates.
    Shoari A; Tahmasebi M; Khodabakhsh F; Cohan RA; Oghalaie A; Behdani M
    Int Immunopharmacol; 2022 Apr; 105():108585. PubMed ID: 35131732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Camelid Single-Domain Antibodies: Promises and Challenges as Lifesaving Treatments.
    Arbabi-Ghahroudi M
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanobodies as therapeutics: big opportunities for small antibodies.
    Steeland S; Vandenbroucke RE; Libert C
    Drug Discov Today; 2016 Jul; 21(7):1076-113. PubMed ID: 27080147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanobodies: From Serendipitous Discovery of Heavy Chain-Only Antibodies in Camelids to a Wide Range of Useful Applications.
    Ji F; Ren J; Vincke C; Jia L; Muyldermans S
    Methods Mol Biol; 2022; 2446():3-17. PubMed ID: 35157266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The development of nanobodies for therapeutic applications.
    Van Bockstaele F; Holz JB; Revets H
    Curr Opin Investig Drugs; 2009 Nov; 10(11):1212-24. PubMed ID: 19876789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanobodies as versatile tools: A focus on targeted tumor therapy, tumor imaging and diagnostics.
    Al-Baradie RS
    Hum Antibodies; 2020; 28(4):259-272. PubMed ID: 32831197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics.
    Bannas P; Hambach J; Koch-Nolte F
    Front Immunol; 2017; 8():1603. PubMed ID: 29213270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caplacizumab to treat immune-mediated thrombotic thrombocytopenic purpura.
    Poullin P; Bornet C; Veyradier A; Coppo P
    Drugs Today (Barc); 2019 Jun; 55(6):367-376. PubMed ID: 31250841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanobodies: from structure to applications in non-injectable and bispecific biotherapeutic development.
    Li B; Qin X; Mi LZ
    Nanoscale; 2022 May; 14(19):7110-7122. PubMed ID: 35535618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.